August 22, 2018
The Ministry of Health, Labor and Welfare (MHLW) approved a series of new indications on August 21, including a label expansion and dosage change for Opdivo (nivolumab), as well as the first-line use of Tagrisso (osimertinib) in non-small cell lung...read more